Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond
In this webinar, you will learn from the Cardinal Health Regulatory Sciences team as they share insights based on recent FDA guidance, CMC best practices, and other important considerations for cell and gene therapy (CGT) development.